PCA
CL icon

Purkiss Capital Advisors’s Colgate-Palmolive CL Stock Holding History

Purkiss Capital Advisors’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$338K Buy
3,683
+1
+0% +$87 0.13% 130
2026
Q1 		$314K Buy
3,682
+1
+0% +$89 0.14% 125
2025
Q4 		$291K Sell
3,681
-298
-7% -$23.4K 0.14% 128
2025
Q3 		$318K Buy
3,979
+1
+0% +$85 0.15% 118
2025
Q2 		$362K Buy
3,978
+1
+0% +$91 0.2% 90
2025
Q1 		$373K Buy
3,977
+2
+0.1% +$179 0.28% 65
2024
Q4 		$361K Buy
+3,975
New +$379K 0.31% 58

Other funds holding CL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Purkiss Capital Advisors's CL Position: Q2 2026 in Review

Purkiss Capital Advisors increased its Colgate-Palmolive (CL) stake by 0.03% in Q2 2026, buying an estimated $87 and bringing the position to 3,683 shares worth $338K. The position accounts for 0.13% of the portfolio, ranked #130.

Purkiss Capital Advisors first reported a position in CL in Q4 2024 and has held it in 7 quarters since. The position peaked at $373K in Q1 2025. 2,022 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Purkiss Capital Advisors held 3,683 shares of Colgate-Palmolive worth $338K as of Q2 2026.
  • Purkiss Capital Advisors bought 1 Colgate-Palmolive share in Q2 2026, an estimated $87.
  • Colgate-Palmolive made up 0.13% of Purkiss Capital Advisors's portfolio in Q2 2026, its #130 holding.
  • Purkiss Capital Advisors first reported a position in Colgate-Palmolive in Q4 2024 and has held it in 7 quarters since.
  • Purkiss Capital Advisors's Colgate-Palmolive position peaked at $373K in Q1 2025.
  • 2,022 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Purkiss Capital Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.